{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T11:23:35Z","timestamp":1740137015902,"version":"3.37.3"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2024,1,18]],"date-time":"2024-01-18T00:00:00Z","timestamp":1705536000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,1,18]],"date-time":"2024-01-18T00:00:00Z","timestamp":1705536000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Bosnalijek d.d."}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Orthop Surg Traumatol"],"DOI":"10.1007\/s00590-023-03786-6","type":"journal-article","created":{"date-parts":[[2024,1,18]],"date-time":"2024-01-18T03:02:46Z","timestamp":1705546966000},"page":"1435-1440","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Therapy adherence, safety and efficacy of rivaroxaban in prevention of venous thromboembolism in patients with hip or knee endoprosthesis"],"prefix":"10.1007","volume":"34","author":[{"given":"Nemanja","family":"Tomi\u0107","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vladimir","family":"An\u0111i\u0107","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dejan","family":"\u0106urlik","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jovica","family":"\u010ceko","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amna","family":"Tanovi\u0107 Avdi\u0107","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Meliha","family":"Mehi\u0107","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aziz","family":"\u0160ukalo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1206-6990","authenticated-orcid":false,"given":"Una","family":"Glamo\u010dlija","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,1,18]]},"reference":[{"key":"3786_CR1","volume-title":"Principles and practice of hospital medicine","author":"M Pai","year":"2017","unstructured":"Pai M, Douketis JD (2017) Venous thromboembolism prophylaxis for hospitalized medical patients. In: McKean SC, Ross JJ, Dressler DD, Scheurer DB (eds) Principles and practice of hospital medicine, 2nd edn. McGraw-Hill Education, New York","edition":"2"},{"key":"3786_CR2","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1002\/rth2.12449","volume":"5","author":"IL Gade","year":"2020","unstructured":"Gade IL, Kold S, Severinsen MT et al (2020) Venous thromboembolism after lower extremity orthopedic surgery: a population-based nationwide cohort study. Res Pract Thromb Haemost 5:148\u2013158. https:\/\/doi.org\/10.1002\/rth2.12449","journal-title":"Res Pract Thromb Haemost"},{"key":"3786_CR3","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1136\/bmj.2.6081.223","volume":"2","author":"JD Stamatakis","year":"1977","unstructured":"Stamatakis JD, Kakkar VV, Sagar S et al (1977) Femoral vein thrombosis and total hip replacement. Br Med J 2:223\u2013225","journal-title":"Br Med J"},{"key":"3786_CR4","unstructured":"VTE epidemiology and challenges for VTE prevention at the population level. https:\/\/www.sciencedirect.com\/science\/article\/pii\/S2666572723000032. Accessed 13 Oct 2023"},{"key":"3786_CR5","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1097\/CORR.0000000000000615","volume":"477","author":"M Sloan","year":"2019","unstructured":"Sloan M, Sheth N, Lee G-C (2019) Is obesity associated with increased risk of deep vein thrombosis or pulmonary embolism after hip and knee arthroplasty? A large database study. Clin Orthop Relat Res 477:523\u2013532. https:\/\/doi.org\/10.1097\/CORR.0000000000000615","journal-title":"Clin Orthop Relat Res"},{"key":"3786_CR6","doi-asserted-by":"publisher","first-page":"139","DOI":"10.3349\/ymj.2015.56.1.139","volume":"56","author":"SY Lee","year":"2015","unstructured":"Lee SY, Ro DH, Chung CY et al (2015) Incidence of deep vein thrombosis after major lower limb orthopedic surgery: analysis of a nationwide claim registry. Yonsei Med J 56:139\u2013145. https:\/\/doi.org\/10.3349\/ymj.2015.56.1.139","journal-title":"Yonsei Med J"},{"key":"3786_CR7","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1016\/j.jor.2020.08.027","volume":"21","author":"GJ Zeng","year":"2020","unstructured":"Zeng GJ, Xu S, Pang HN (2020) Incidence of deep vein thrombosis and pulmonary embolism in Asian patients after direct anterior total hip arthroplasty. J Orthop 21:528\u2013531. https:\/\/doi.org\/10.1016\/j.jor.2020.08.027","journal-title":"J Orthop"},{"key":"3786_CR8","doi-asserted-by":"publisher","first-page":"1056","DOI":"10.1161\/ATVBAHA.115.303397","volume":"35","author":"CH Yeh","year":"2015","unstructured":"Yeh CH, Hogg K, Weitz JI (2015) Overview of the new oral anticoagulants. Arterioscler Thromb Vasc Biol 35:1056\u20131065. https:\/\/doi.org\/10.1161\/ATVBAHA.115.303397","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"3786_CR9","first-page":"189","volume":"8","author":"SC Florescu","year":"2013","unstructured":"Florescu SC, Anastase DM, Munteanu AM et al (2013) Venous thromboembolism following major orthopedic surgery. Maedica (Bucur) 8:189\u2013194","journal-title":"Maedica (Bucur)"},{"key":"3786_CR10","doi-asserted-by":"publisher","first-page":"2374","DOI":"10.1161\/CIRCULATIONAHA.106.642074","volume":"114","author":"BI Eriksson","year":"2006","unstructured":"Eriksson BI, Borris LC, Dahl OE et al (2006) A once-daily, oral, direct factor Xa inhibitor, rivaroxaban (BAY 59\u20137939), for thromboprophylaxis after total hip replacement. Circulation 114:2374\u20132381. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.106.642074","journal-title":"Circulation"},{"key":"3786_CR11","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000014539","volume":"98","author":"J Liu","year":"2019","unstructured":"Liu J, Zhao J, Yan Y, Su J (2019) Effectiveness and safety of rivaroxaban for the prevention of thrombosis following total hip or knee replacement: a systematic review and meta-analysis. Medicine (Baltimore) 98:e14539. https:\/\/doi.org\/10.1097\/MD.0000000000014539","journal-title":"Medicine (Baltimore)"},{"key":"3786_CR12","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1160\/TH13-08-0666","volume":"111","author":"AGG Turpie","year":"2014","unstructured":"Turpie AGG, Haas S, Kreutz R et al (2014) A non-interventional comparison of rivaroxaban with standard of care for thromboprophylaxis after major orthopaedic surgery in 17,701 patients with propensity score adjustment. Thromb Haemost 111:94\u2013102. https:\/\/doi.org\/10.1160\/TH13-08-0666","journal-title":"Thromb Haemost"},{"key":"3786_CR13","doi-asserted-by":"publisher","first-page":"143","DOI":"10.2147\/CPAA.S26647","volume":"5","author":"LM Kwong","year":"2013","unstructured":"Kwong LM (2013) Comparative safety and efficacy of antithrombotics in the management of venous thromboembolism after knee or hip replacement surgery: focus on rivaroxaban. Clin Pharmacol 5:143\u2013148. https:\/\/doi.org\/10.2147\/CPAA.S26647","journal-title":"Clin Pharmacol"},{"key":"3786_CR14","doi-asserted-by":"publisher","first-page":"1673","DOI":"10.1016\/S0140-6736(09)60734-0","volume":"373","author":"AGG Turpie","year":"2009","unstructured":"Turpie AGG, Lassen MR, Davidson BL et al (2009) Rivaroxaban versus enoxaparin for thromboprophylaxis after total knee arthroplasty (RECORD4): a randomised trial. Lancet 373:1673\u20131680. https:\/\/doi.org\/10.1016\/S0140-6736(09)60734-0","journal-title":"Lancet"},{"key":"3786_CR15","doi-asserted-by":"publisher","first-page":"157","DOI":"10.2147\/VHRM.S54714","volume":"10","author":"B Levitan","year":"2014","unstructured":"Levitan B, Yuan Z, Turpie AGG et al (2014) Benefit-risk assessment of rivaroxaban versus enoxaparin for the prevention of venous thromboembolism after total hip or knee arthroplasty. Vasc Health Risk Manag 10:157\u2013167. https:\/\/doi.org\/10.2147\/VHRM.S54714","journal-title":"Vasc Health Risk Manag"},{"key":"3786_CR16","doi-asserted-by":"publisher","first-page":"1299","DOI":"10.1007\/s00264-011-1466-5","volume":"36","author":"L Markovic-Denic","year":"2012","unstructured":"Markovic-Denic L, Zivkovic K, Lesic A et al (2012) Risk factors and distribution of symptomatic venous thromboembolism in total hip and knee replacements: prospective study. Int Orthop 36:1299\u20131305. https:\/\/doi.org\/10.1007\/s00264-011-1466-5","journal-title":"Int Orthop"},{"key":"3786_CR17","unstructured":"Rates of symptomatic venous thromboembolism in US surgical patients: a retrospective administrative database study. https:\/\/pubmed.ncbi.nlm.nih.gov\/19479199\/. Accessed 24 Jul 2023"},{"key":"3786_CR18","unstructured":"Assessment of knowledge, attitude, practice and associated factors of venous thromboembolism prophylaxis among health professionals. A cross sectional study. https:\/\/www.sciencedirect.com\/science\/article\/pii\/S2405857221001273. Accessed 24 Jul 2023"},{"key":"3786_CR19","unstructured":"SmpC River 30x20 mg film tablets 07.07.2023. 04-07.3-1-3013\/20"},{"key":"3786_CR20","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1097\/00005650-198601000-00007","volume":"24","author":"DE Morisky","year":"1986","unstructured":"Morisky DE, Green LW, Levine DM (1986) Concurrent and predictive validity of a self-reported measure of medication adherence. Med Care 24:67","journal-title":"Med Care"},{"key":"3786_CR21","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1055\/s-0039-1697954","volume":"120","author":"J Hwang","year":"2020","unstructured":"Hwang J, Han S, Bae H-J et al (2020) NOAC adherence of patients with atrial fibrillation in the real world: dosing frequency matters? Thromb Haemost 120:306\u2013313. https:\/\/doi.org\/10.1055\/s-0039-1697954","journal-title":"Thromb Haemost"},{"key":"3786_CR22","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1055\/s-0041-1731657","volume":"56","author":"LMAT Viana","year":"2021","unstructured":"Viana LMAT, Nogueira IAL, Fontenele AMM, de Oliveira LP (2021) Thromboembolism in arthroplasty: compliance to prophylaxis. Rev Bras Ortop (Sao Paulo) 56:647\u2013655. https:\/\/doi.org\/10.1055\/s-0041-1731657","journal-title":"Rev Bras Ortop (Sao Paulo)"},{"key":"3786_CR23","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1186\/s13018-018-0813-2","volume":"13","author":"Y Xu","year":"2018","unstructured":"Xu Y, Zhao J, Chen Y (2018) Prevention of venous thromboembolism in patients undergoing major orthopedic surgery in China: a qualitative study of patients\u2019 perceptions. J Orthop Surg Res 13:98. https:\/\/doi.org\/10.1186\/s13018-018-0813-2","journal-title":"J Orthop Surg Res"},{"key":"3786_CR24","unstructured":"Patient compliance with deep vein thrombosis prophylaxis after total hip and total knee arthroplasty. https:\/\/pubmed.ncbi.nlm.nih.gov\/31285809\/ Accessed 24 Jul 2023"},{"key":"3786_CR25","doi-asserted-by":"publisher","first-page":"1","DOI":"10.2147\/ORR.S105227","volume":"9","author":"J Beyer-Westendorf","year":"2017","unstructured":"Beyer-Westendorf J, Mouret P, Turpie AG (2017) Rivaroxaban for venous thromboembolism prevention after major orthopedic surgery: translating trial data into routine clinical practice. Orthop Res Rev 9:1\u201311. https:\/\/doi.org\/10.2147\/ORR.S105227","journal-title":"Orthop Res Rev"},{"key":"3786_CR26","doi-asserted-by":"publisher","first-page":"1554","DOI":"10.2106\/JBJS.K.00521","volume":"94","author":"SS Jameson","year":"2012","unstructured":"Jameson SS, Rymaszewska M, Hui ACW et al (2012) Wound complications following rivaroxaban administration: a multicenter comparison with low-molecular-weight heparins for thromboprophylaxis in lower limb arthroplasty. J Bone Jt Surg Am 94:1554\u20131558. https:\/\/doi.org\/10.2106\/JBJS.K.00521","journal-title":"J Bone Jt Surg Am"},{"key":"3786_CR27","doi-asserted-by":"publisher","first-page":"125","DOI":"10.5604\/15093492.1045953","volume":"15","author":"GS Chahal","year":"2013","unstructured":"Chahal GS, Saithna A, Brewster M et al (2013) A comparison of complications requiring return to theatre in hip and knee arthroplasty patients taking enoxaparin versus rivaroxaban for thromboprophylaxis. Ortop Traumatol Rehabil 15:125\u2013129. https:\/\/doi.org\/10.5604\/15093492.1045953","journal-title":"Ortop Traumatol Rehabil"},{"key":"3786_CR28","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1302\/0301-620X.93B1.24987","volume":"93","author":"CD Jensen","year":"2011","unstructured":"Jensen CD, Steval A, Partington PF et al (2011) Return to theatre following total hip and knee replacement, before and after the introduction of rivaroxaban: a retrospective cohort study. J Bone Jt Surg Br 93:91\u201395. https:\/\/doi.org\/10.1302\/0301-620X.93B1.24987","journal-title":"J Bone Jt Surg Br"},{"key":"3786_CR29","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1016\/j.knee.2013.01.006","volume":"20","author":"NK Rath","year":"2013","unstructured":"Rath NK, Goodson MW, White SP, Forster MC (2013) The use of rivaroxaban for chemical thromboprophylaxis following total knee replacement. Knee 20:397\u2013400. https:\/\/doi.org\/10.1016\/j.knee.2013.01.006","journal-title":"Knee"},{"key":"3786_CR30","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1111\/1469-0691.12209","volume":"20","author":"K Carroll","year":"2014","unstructured":"Carroll K, Dowsey M, Choong P, Peel T (2014) Risk factors for superficial wound complications in hip and knee arthroplasty. Clin Microbiol Infect 20:130\u2013135. https:\/\/doi.org\/10.1111\/1469-0691.12209","journal-title":"Clin Microbiol Infect"},{"key":"3786_CR31","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/s13018-016-0340-y","volume":"11","author":"K Harato","year":"2016","unstructured":"Harato K, Tanikawa H, Morishige Y et al (2016) What are the important surgical factors affecting the wound healing after primary total knee arthroplasty? J Orthop Surg Res 11:7. https:\/\/doi.org\/10.1186\/s13018-016-0340-y","journal-title":"J Orthop Surg Res"},{"key":"3786_CR32","doi-asserted-by":"publisher","first-page":"29","DOI":"10.5603\/AH.2017.0004","volume":"21","author":"P \u0141\u0119gosz","year":"2017","unstructured":"\u0141\u0119gosz P, P\u0142atek AE, Kotkowski M et al (2017) Clinical characteristics of hypertensive patients undergoing total hip or knee replacement. Arter Hypertens 21:29\u201333. https:\/\/doi.org\/10.5603\/AH.2017.0004","journal-title":"Arter Hypertens"},{"key":"3786_CR33","doi-asserted-by":"publisher","first-page":"1969","DOI":"10.1055\/s-0042-1757200","volume":"122","author":"U Gurunathan","year":"2022","unstructured":"Gurunathan U, Barras M, McDougall C et al (2022) Obesity and the risk of venous thromboembolism after major lower limb orthopaedic surgery: a literature review. Thromb Haemost 122:1969\u20131979. https:\/\/doi.org\/10.1055\/s-0042-1757200","journal-title":"Thromb Haemost"},{"key":"3786_CR34","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1186\/s12891-021-04417-z","volume":"22","author":"X Yu","year":"2021","unstructured":"Yu X, Wu Y, Ning R (2021) The deep vein thrombosis of lower limb after total hip arthroplasty: what should we care. BMC Musculoskelet Disord 22:547. https:\/\/doi.org\/10.1186\/s12891-021-04417-z","journal-title":"BMC Musculoskelet Disord"},{"key":"3786_CR35","doi-asserted-by":"publisher","first-page":"1696","DOI":"10.1038\/s41366-021-00832-3","volume":"45","author":"X Jin","year":"2021","unstructured":"Jin X, Gibson AA, Gale J et al (2021) Does weight loss reduce the incidence of total knee and hip replacement for osteoarthritis?\u2014a prospective cohort study among middle-aged and older adults with overweight or obesity. Int J Obes (Lond) 45:1696\u20131704. https:\/\/doi.org\/10.1038\/s41366-021-00832-3","journal-title":"Int J Obes (Lond)"},{"key":"3786_CR36","doi-asserted-by":"publisher","first-page":"e0187139","DOI":"10.1371\/journal.pone.0187139","volume":"12","author":"SJ Moon","year":"2017","unstructured":"Moon SJ, Lee W-Y, Hwang JS et al (2017) Accuracy of a screening tool for medication adherence: a systematic review and meta-analysis of the Morisky Medication Adherence Scale-8. PLoS ONE 12:e0187139. https:\/\/doi.org\/10.1371\/journal.pone.0187139","journal-title":"PLoS ONE"}],"container-title":["European Journal of Orthopaedic Surgery & Traumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00590-023-03786-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00590-023-03786-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00590-023-03786-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,29]],"date-time":"2024-03-29T18:04:24Z","timestamp":1711735464000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00590-023-03786-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1,18]]},"references-count":36,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2024,4]]}},"alternative-id":["3786"],"URL":"https:\/\/doi.org\/10.1007\/s00590-023-03786-6","relation":{},"ISSN":["1432-1068"],"issn-type":[{"type":"electronic","value":"1432-1068"}],"subject":[],"published":{"date-parts":[[2024,1,18]]},"assertion":[{"value":"28 July 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 November 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 January 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Amna Tanovi\u0107 Avdi\u0107, Meliha Mehi\u0107, Aziz \u0160ukalo, Una Glamo\u010dlija disclose the following relationships\u2014employees of Bosnalijek d.d., a pharmaceutical company producing rivaroxaban-based medicine. Bosnalijek d.d. had a role in the design of the study; in the collection, analyses, and interpretation of data; in the writing of the manuscript, and in the decision to publish the results.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The clinical trial was approved by the Agency for medicinal products and medical devices of Bosnia and Herzegovina. In all procedures the Helsinki Declaration from 1975 and its amendments from 1983 were followed.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Before any procedure started, each patient signed an informed consent form.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}